CN105118519A
|
|
Hearing evaluation system
|
CN104911183A
|
|
Transcription template of shRNA for inhibiting expression of pancreatic cancer TAK1 gene
|
CN105078948A
|
|
Application of P2X7 receptor inhibitor
|
CN105169402A
|
|
Drug loaded nanometer particle for targeting immunotherapy of pancreatic cancer
|
CN104651309A
|
|
Sorting and amplification method of human peripheral blood CD4+CD25+Foxp3+ regulatory T cells
|
CN104436214A
|
|
Application of TIMP-1 (tissue inhibitor of metalloproteinase-1) gene in preparation of product for treating diabetic skin ulcers
|
CN104109718A
|
|
Application of ARAF gene in preparation of product for diagnosing idiopathic dwarfism
|
CN104922155A
|
|
Cell feeding method for treating heart disease
|
CN103830205A
|
|
Soluble thrombin nano-particle, and preparation method and application thereof
|
CN103405783A
|
|
OX26/CTX-PL/pC27 compound and application of OX26/CTX-PL/pC27 compound in treating gliomas
|
CN103315724A
|
|
Hyperbaric oxygen chamber treatment monitoring system
|
CN102895219A
|
|
Application of astaxanthin in fetal alcohol spectrum disorders (FASD)
|
CN102160895A
|
|
Application of PITPNM3 gene in preparing medicine for inhibiting breast cancer invasion and transfer
|
CN102199297A
|
|
Star-shaped cationic polymer, preparation method thereof and application thereof
|
CN101940796A
|
|
Preparation of gene immunization treating tumor used for vein
|